VWM
BSX icon

Vermillion Wealth Management’s Boston Scientific BSX Stock Holding History

Vermillion Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9
Closed -$565 – 1666
2026
Q1 		$565 Buy
+9
New +$720 ﹤0.01% 971

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vermillion Wealth Management's BSX Position: Q2 2026 in Review

Vermillion Wealth Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 9 shares — an estimated $565 sold.

Vermillion Wealth Management first reported a position in BSX in Q1 2026 and held it in 1 quarter. The position peaked at $565 in Q1 2026. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Vermillion Wealth Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Vermillion Wealth Management sold 9 Boston Scientific shares in Q2 2026, an estimated $565.
  • Vermillion Wealth Management first reported a position in Boston Scientific in Q1 2026 and held it in 1 quarter.
  • Vermillion Wealth Management's Boston Scientific position peaked at $565 in Q1 2026.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.